US Stock MarketDetailed Quotes

Alnylam Pharmaceuticals (ALNY)

Watchlist
  • 296.110
  • -13.380-4.32%
Close May 1 15:59 ET
  • 296.120
  • +0.010+0.00%
Post 16:22 ET
39.53BMarket Cap74.40P/E (TTM)

Alnylam Pharmaceuticals (ALNY) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
158.60%70.5M
6,405.10%524.08M
272.78%163.56M
643.84%325.11M
25.43%155.73M
-47.59%-120.31M
-107.98%-8.31M
-217.71%-94.66M
-87.84%43.71M
310.49%124.16M
Net income from continuing operations
1,228.66%205.99M
212.79%313.75M
322.56%186.42M
325.05%251.08M
-524.70%-105.51M
72.32%-18.25M
36.82%-278.16M
39.24%-83.76M
-175.51%-111.57M
93.88%-16.89M
Operating gains losses
----
-98.67%2.31M
-352.65%-177.96M
174.35%103.81M
32.62%75.5M
-88.87%956K
61.01%173.79M
215.37%70.44M
-21.26%37.84M
97.57%56.93M
Depreciation and amortization
-5.91%13.55M
-1.79%55.66M
-4.67%13.51M
-1.28%13.8M
-7.06%13.94M
6.57%14.41M
4.84%56.67M
174.55%14.17M
-40.58%13.98M
-36.01%15M
Deferred tax
-3.41%9.31M
97.94%-2.2M
74.70%-27.17M
3,534.36%5.6M
2,763.24%9.74M
2,023.13%9.64M
-14,873.63%-106.76M
---107.39M
---163K
--340K
Other non cash items
96.28%69.23M
184.89%251.11M
496.66%170.28M
181.42%47.26M
-109.58%-1.7M
40.79%35.27M
-15.39%88.15M
180.65%28.54M
-66.82%16.8M
-27.21%17.76M
Change In working capital
-35.92%-297.73M
-107.76%-444.78M
32.45%-73.15M
-598.92%-204.66M
235.78%52.08M
-101.96%-219.04M
-473.87%-214.08M
-303.20%-108.3M
60.70%41.02M
-159.39%-38.35M
-Change in receivables
-1,385.35%-110.42M
-315.90%-359.96M
409.62%184.25M
-978.03%-399.86M
-1,520.26%-136.91M
-1,913.17%-7.43M
1.58%-86.55M
-1,638.07%-59.51M
65.65%-37.09M
424.58%9.64M
-Change in inventory
-153.48%-3.32M
-37.65%8.47M
-1,732.63%-13.86M
-16.02%4.98M
64.03%11.14M
28,150.00%6.22M
-26.01%13.59M
-92.92%849K
23.57%5.93M
242.27%6.79M
-Change in prepaid assets
80.70%-6.32M
-3,745.83%-117.72M
-380.80%-70.99M
-150.60%-20.74M
-89.01%6.78M
56.58%-32.77M
135.76%3.23M
8.05%25.28M
-149.46%-8.28M
321.31%61.69M
-Change in payables and accrued expense
-11.60%-176.03M
-17.59%75.07M
-181.54%-174.85M
167.37%223.51M
147.28%184.15M
-3,142.24%-157.74M
12.68%91.09M
-60.62%-62.11M
-29.60%83.6M
-10.00%74.47M
-Change in other current liabilities
----
----
----
----
----
----
----
----
-25.78%-14.05M
0.63%-10.95M
-Change in other working capital
94.02%-1.63M
78.49%-50.64M
117.99%2.31M
-300.64%-12.54M
93.15%-13.08M
4.35%-27.32M
-527.91%-235.45M
-172.42%-12.81M
-112.79%-3.13M
-979.27%-190.94M
Cash from discontinued investing activities
Operating cash flow
158.60%70.5M
6,405.10%524.08M
272.78%163.56M
643.84%325.11M
25.43%155.73M
-47.59%-120.31M
-107.98%-8.31M
-217.71%-94.66M
-87.84%43.71M
310.49%124.16M
Investing cash flow
Cash flow from continuing investing activities
-122.45%-25.54M
473.44%436.33M
29.76%-37.17M
1,756.55%501.11M
-516.56%-141.38M
268.25%113.77M
65.26%-116.84M
78.01%-52.91M
-181.03%-30.25M
489.53%33.94M
Net PPE purchase and sale
-143.40%-21.83M
-71.24%-58.7M
-156.12%-23.29M
-189.65%-12.14M
-78.26%-14.29M
30.86%-8.97M
44.90%-34.28M
40.60%-9.09M
75.47%-4.19M
49.63%-8.02M
Net investment purchase and sale
-139.46%-48.43M
886.10%497.18M
68.25%-13.87M
7,615.30%515.4M
-402.89%-127.09M
324.60%122.74M
76.55%-63.25M
80.61%-43.7M
-163.70%-6.86M
482.26%41.96M
Net other investing changes
--44.73M
88.87%-2.15M
--0
----
----
----
-335.26%-19.32M
---117K
----
----
Cash from discontinued investing activities
Investing cash flow
-122.45%-25.54M
473.44%436.33M
29.76%-37.17M
1,756.55%501.11M
-516.56%-141.38M
268.25%113.77M
65.26%-116.84M
78.01%-52.91M
-181.03%-30.25M
489.53%33.94M
Financing cash flow
Cash flow from continuing financing activities
-65.90%15.71M
-203.75%-305.19M
46.20%45.32M
-536.33%-448.35M
-60.64%51.76M
59.39%46.08M
70.89%294.16M
-20.98%31M
210.08%102.76M
146.27%131.5M
Net issuance payments of debt
----
---544.53M
---52.93M
----
----
----
--0
--0
----
----
Proceeds from stock option exercised by employees
-73.35%13.16M
-17.47%250.03M
14.95%41.7M
-28.04%77.74M
-38.83%81.22M
90.90%49.37M
105.44%302.95M
17.43%36.28M
335.54%108.04M
168.81%132.78M
Net other financing activities
177.89%2.56M
-21.54%-10.69M
1,170.82%56.55M
-553.10%-34.49M
-2,198.21%-29.46M
-207.57%-3.28M
-135.64%-8.79M
-163.37%-5.28M
-163.37%-5.28M
-132.05%-1.28M
Cash from discontinued financing activities
Financing cash flow
-65.90%15.71M
-203.75%-305.19M
46.20%45.32M
-536.33%-448.35M
-60.64%51.76M
59.39%46.08M
70.89%294.16M
-20.98%31M
210.08%102.76M
146.27%131.5M
Net cash flow
Beginning cash position
71.25%1.66B
18.87%968.65M
35.40%1.49B
14.90%1.12B
49.29%1.02B
18.87%968.65M
-6.18%814.88M
6.50%1.1B
47.16%971.19M
1.53%684.72M
Current changes in cash
53.46%60.68M
287.69%655.22M
247.29%171.71M
225.15%377.87M
-77.17%66.11M
132.89%39.54M
381.38%169.01M
49.58%-116.58M
-69.56%116.21M
2,124.43%289.59M
Effect of exchange rate changes
-150.25%-7.06M
329.25%34.94M
66.99%-5.7M
-106.14%-927K
981.60%27.51M
241.41%14.06M
-338.44%-15.24M
-258.49%-17.27M
330.36%15.09M
-2,300.00%-3.12M
End cash Position
67.51%1.71B
71.25%1.66B
71.25%1.66B
35.40%1.49B
14.90%1.12B
49.29%1.02B
18.87%968.65M
18.87%968.65M
6.50%1.1B
47.16%971.19M
Free cash flow
137.65%48.67M
1,192.73%465.38M
235.19%140.26M
692.02%312.97M
21.78%141.44M
-36.82%-129.28M
-201.54%-42.59M
-130.04%-103.76M
-88.46%39.52M
255.05%116.14M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 158.60%70.5M6,405.10%524.08M272.78%163.56M643.84%325.11M25.43%155.73M-47.59%-120.31M-107.98%-8.31M-217.71%-94.66M-87.84%43.71M310.49%124.16M
Net income from continuing operations 1,228.66%205.99M212.79%313.75M322.56%186.42M325.05%251.08M-524.70%-105.51M72.32%-18.25M36.82%-278.16M39.24%-83.76M-175.51%-111.57M93.88%-16.89M
Operating gains losses -----98.67%2.31M-352.65%-177.96M174.35%103.81M32.62%75.5M-88.87%956K61.01%173.79M215.37%70.44M-21.26%37.84M97.57%56.93M
Depreciation and amortization -5.91%13.55M-1.79%55.66M-4.67%13.51M-1.28%13.8M-7.06%13.94M6.57%14.41M4.84%56.67M174.55%14.17M-40.58%13.98M-36.01%15M
Deferred tax -3.41%9.31M97.94%-2.2M74.70%-27.17M3,534.36%5.6M2,763.24%9.74M2,023.13%9.64M-14,873.63%-106.76M---107.39M---163K--340K
Other non cash items 96.28%69.23M184.89%251.11M496.66%170.28M181.42%47.26M-109.58%-1.7M40.79%35.27M-15.39%88.15M180.65%28.54M-66.82%16.8M-27.21%17.76M
Change In working capital -35.92%-297.73M-107.76%-444.78M32.45%-73.15M-598.92%-204.66M235.78%52.08M-101.96%-219.04M-473.87%-214.08M-303.20%-108.3M60.70%41.02M-159.39%-38.35M
-Change in receivables -1,385.35%-110.42M-315.90%-359.96M409.62%184.25M-978.03%-399.86M-1,520.26%-136.91M-1,913.17%-7.43M1.58%-86.55M-1,638.07%-59.51M65.65%-37.09M424.58%9.64M
-Change in inventory -153.48%-3.32M-37.65%8.47M-1,732.63%-13.86M-16.02%4.98M64.03%11.14M28,150.00%6.22M-26.01%13.59M-92.92%849K23.57%5.93M242.27%6.79M
-Change in prepaid assets 80.70%-6.32M-3,745.83%-117.72M-380.80%-70.99M-150.60%-20.74M-89.01%6.78M56.58%-32.77M135.76%3.23M8.05%25.28M-149.46%-8.28M321.31%61.69M
-Change in payables and accrued expense -11.60%-176.03M-17.59%75.07M-181.54%-174.85M167.37%223.51M147.28%184.15M-3,142.24%-157.74M12.68%91.09M-60.62%-62.11M-29.60%83.6M-10.00%74.47M
-Change in other current liabilities ---------------------------------25.78%-14.05M0.63%-10.95M
-Change in other working capital 94.02%-1.63M78.49%-50.64M117.99%2.31M-300.64%-12.54M93.15%-13.08M4.35%-27.32M-527.91%-235.45M-172.42%-12.81M-112.79%-3.13M-979.27%-190.94M
Cash from discontinued investing activities
Operating cash flow 158.60%70.5M6,405.10%524.08M272.78%163.56M643.84%325.11M25.43%155.73M-47.59%-120.31M-107.98%-8.31M-217.71%-94.66M-87.84%43.71M310.49%124.16M
Investing cash flow
Cash flow from continuing investing activities -122.45%-25.54M473.44%436.33M29.76%-37.17M1,756.55%501.11M-516.56%-141.38M268.25%113.77M65.26%-116.84M78.01%-52.91M-181.03%-30.25M489.53%33.94M
Net PPE purchase and sale -143.40%-21.83M-71.24%-58.7M-156.12%-23.29M-189.65%-12.14M-78.26%-14.29M30.86%-8.97M44.90%-34.28M40.60%-9.09M75.47%-4.19M49.63%-8.02M
Net investment purchase and sale -139.46%-48.43M886.10%497.18M68.25%-13.87M7,615.30%515.4M-402.89%-127.09M324.60%122.74M76.55%-63.25M80.61%-43.7M-163.70%-6.86M482.26%41.96M
Net other investing changes --44.73M88.87%-2.15M--0-------------335.26%-19.32M---117K--------
Cash from discontinued investing activities
Investing cash flow -122.45%-25.54M473.44%436.33M29.76%-37.17M1,756.55%501.11M-516.56%-141.38M268.25%113.77M65.26%-116.84M78.01%-52.91M-181.03%-30.25M489.53%33.94M
Financing cash flow
Cash flow from continuing financing activities -65.90%15.71M-203.75%-305.19M46.20%45.32M-536.33%-448.35M-60.64%51.76M59.39%46.08M70.89%294.16M-20.98%31M210.08%102.76M146.27%131.5M
Net issuance payments of debt -------544.53M---52.93M--------------0--0--------
Proceeds from stock option exercised by employees -73.35%13.16M-17.47%250.03M14.95%41.7M-28.04%77.74M-38.83%81.22M90.90%49.37M105.44%302.95M17.43%36.28M335.54%108.04M168.81%132.78M
Net other financing activities 177.89%2.56M-21.54%-10.69M1,170.82%56.55M-553.10%-34.49M-2,198.21%-29.46M-207.57%-3.28M-135.64%-8.79M-163.37%-5.28M-163.37%-5.28M-132.05%-1.28M
Cash from discontinued financing activities
Financing cash flow -65.90%15.71M-203.75%-305.19M46.20%45.32M-536.33%-448.35M-60.64%51.76M59.39%46.08M70.89%294.16M-20.98%31M210.08%102.76M146.27%131.5M
Net cash flow
Beginning cash position 71.25%1.66B18.87%968.65M35.40%1.49B14.90%1.12B49.29%1.02B18.87%968.65M-6.18%814.88M6.50%1.1B47.16%971.19M1.53%684.72M
Current changes in cash 53.46%60.68M287.69%655.22M247.29%171.71M225.15%377.87M-77.17%66.11M132.89%39.54M381.38%169.01M49.58%-116.58M-69.56%116.21M2,124.43%289.59M
Effect of exchange rate changes -150.25%-7.06M329.25%34.94M66.99%-5.7M-106.14%-927K981.60%27.51M241.41%14.06M-338.44%-15.24M-258.49%-17.27M330.36%15.09M-2,300.00%-3.12M
End cash Position 67.51%1.71B71.25%1.66B71.25%1.66B35.40%1.49B14.90%1.12B49.29%1.02B18.87%968.65M18.87%968.65M6.50%1.1B47.16%971.19M
Free cash flow 137.65%48.67M1,192.73%465.38M235.19%140.26M692.02%312.97M21.78%141.44M-36.82%-129.28M-201.54%-42.59M-130.04%-103.76M-88.46%39.52M255.05%116.14M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More